Poster Information
Partial List of Confirmed Poster Titles
- 2-D and 3-D Paper-Based Microfluidic Devices for Detection of Intestinal Pathogens
- 8-Plex Real-Time PCR for SNP and InDel Detection in a Single Fluorescence Channel Using PNA Probes
- A Cross-Platform Validation Study of EGFR-Activating Mutations in Non-Small Cell Lung Carcinoma Cells
- A New Companion Diagnostic Test for the Detection of BRAF V600E and V600K Mutations in FFPE Samples from Melanoma Patients
- A New Dimension in Biomarker Research: Application of the High-Throughput GlycanMap® Platform to Discovery of Novel Glycomic Biomarkers
- A New Technology for the Preparation of PCR-Freeand Low-Input NGS Libraries
- A Novel Lateral Flow Assay Utilizing Near-Infrared Dye for Multiplex Detection
- A Novel Mechanism of MicroRNA in Regulating Glioblastoma Cell Response to Stress
- A Review of High Sensitivity Digital Immunoassays in PK/PD Studies
- A Study of Protein Changes in Duchenne Muscular Dystrophy Using SOMAscan™ Multiplex Proteomic Technology
- A Study on Various Combinations of CK-Antibodies and Various Cancers
- Advanced Single Molecular Detection: Accelerating Biomarker Development Through Ultrasensitive Immunoassay Technology
- All-in-One Tube: Simultaneous Detection of Chikungunya and Dengue Viruses with Dengue Serotype-Specific Confirmation qRT-PCR Assay
- An Assay Developer's Tool to Enhance Diagnostic Surfaces and Improve Assay Performance
- Analysis of Circulating Tumor Cells in Breast Cancer Using Size-Based Separation and Automated Image Analysis
- Animal Models of Colorectal Cancer
- Applications of Synthetic RNAs: (1) Tools for IVD and Companion Diagnostics, Manufactured in Compliance with cGMP Requirements (2) Highly Modified Synthetic mRNAs for Programmed Changes in Cellular Expression Patterns
- Azymetric™ Scaffold – Optimized Fc Heterodimer for Improved Purity and Stability in the Development of Bispecific Antibodies
- Biomarker Discovery and Validation Through RNA-seq Analysis of Prostate Cancer Patient Cohort
- Blood Transcriptomic Biomarker Identification for Healthy Control, MCI, AD and EHT 0202 Treated AD Patient Segregation
- Bridging the Knowledge Gap: Searching SharePoint, E-Notebook, Chromatography Data Systems and Unstructured Documents for Chemical and Other Scientific Information to Enable Cooperation, Collaboration and Improved Decision Making
- Chemical Variant of 7-deaza-dGTP for Improved GC-Rich PCR and Amplification
- CI Slide: A New Calibration Imaging Slide for Quantitative Microscopy Imaging in Absorbance
- Clustering of Small Molecules Based on Similarity Scores from Flexible 3D Alignment
- Comparative Secretome Analyses Using a Hollow Fiber Culture System with Label-Free Quantitative Proteomics Indicates the Influence of PARK7 on Cell Proliferation and Migration/Invasion in Lung Adenocarcinoma
- Complete Regression of Metastatic Renal Cell Carcinoma by Multiple Injections of Engineered Mesenchymal Stem Cells Expressing Dodecameric TRAIL and HSV-TK
- Crowdsourcing New Chemical Entities: Development of a Submission Interface to Asses Relevance for Open Innovation Projects
- Deconvolving Cell Type-Specific Signals from Whole Blood Transcriptomes
- Design, Synthesis and Evaluation of Macrocyclic Kinase Inhibitors
- Detecting Translocations from Whole-Genome Sequencing of ALL Samples
- Developing an Expert Finding System using Medical Subject Headings (MeSH)
- Developing New Mucosal Vaccine Strategy by Increasing Cytolytic CD4+/CD8+ T Cells Ratio Using B-T Constructs of Y. pestis in Microspheres
- Development of Multi-Marker Panel for Pancreatic Cancer Using Multiple Reaction Monitoring
- Development of Multiple SNPs Genotyping Method using PNA Probe-based Fluorescence Melting Curve Analysis Technology
- Development of Quantitative B-Raf, EGFR, K-Ras and PI3Ka FFPE Molecular Reference Standards
- Differential Biomarker Expression in Colorectal, Lung, Anal, and Head and Neck Carcinomas Predict Sensitivity or Resistance to Combined Targeted Therapy of Lapatinib and Cetuximab: Implications for Therapy
- Discovery of Neurological Biomarker Signatures Using SOMAscan™ Multiplex Proteomic Technology
- DNA Mutational Analysis of Circulating Tumor Cells (CTCs) Using the IsoFlux System and a High-Sensitivity TaqMan Mutation Detection Assay (castPCR)
- Effect of MicroRNA GC Content on RNA Purification Efficiency from Biological and Clinical Specimens Using Various Isolation Procedures
- Electronic Nanopore Sequencing
- Epidermal Growth Factor Receptor Immunohistochemistry Image Analysis in Advanced Colorectal Cancer
- Evaluation of a Targeted DNA Sequencing Assay in Myelodysplastic Syndromes: Early Experience at Genoptix Medical Laboratory
- Evaluation of Genomic DNA Purification from Human Whole Blood Using the Maxwell® CSC Automated Nucleic Acid Extraction System and Maxwell® CSC Blood Reagents
- Exploration of Autoantibody Profiles in Cancer Patients: Implications for the Diagnosis, Prognosis and Prediction of Response to Immunotherapy
- Frequency and Co-Occurrence of MAPK and PI3K Pathway Driver Mutations to Guide Single-Agent and Combination Therapies: An Analysis of Next Generation Sequence Data from 2700 Patients
- High Dynamic Range Magnetic Nanoparticle Sensing for Multiplexed Protein Assays
- Highly Sensitive Detection of Tumor Mutations in Plasma Using Allele Enrichment Combined with Next-Generation Sequencing
- Hot Start dNTPs—Pushing the Limits of PCR and qPCR
- Identification of a Novel Metastasis Suppressor Using an Integrative Approach
- In Silico Development of New Therapeutic Agents for Hypercholesterolemia: Inhibitors of the PCSK9 Interaction with LDLR
- In Silico Study of Rhamnolipids
- Inhibition of AKR1C3 Can Partially Prevent Hormone-Dependent Cell Proliferation in Castration-Resistant Prostate Cancer and Estrogen Receptor Positive Breast Cancer Cell Lines
- Innovative Primary Culture of Cancer Tissue-Originated Spheroid (CTOS) for Drug/Biomarker Screening and Xenograft Models
- Integration and Data Mining on Public Cancer Genome Databases
- Intra-Lymph Node Immunization with Vaccines and Adjuvants for Treatment of Cancer
- Isolation of Circulating Tumor Cells in Colorectal Cancer Using a Microsieve System
- Isolation of High Quality FFPE RNA from Challenging Samples
- Isothermal Enzyme-Free Detection of SNPs via Hybridization Chain Reaction
- KRAS Mutational Analysis of Circulating Tumor Cells (CTCs) Using the IsoFlux System and Droplet Digital PCR
- Large Scale, Quantitative Molecular Image Analysis and Imaging Informatics
- Life Chemicals Targeted Libraries
- Life Technologies’ New SYBR® Select Master Mix: The Next Generation SYBR® qPCR Master Mix
- Life Technologies’ TaqMan® miRNA ABC Purification Kit – A Sample-to-Solution Approach To Purify High Quality Specific MicroRNA For Down Stream Applications
- Magnetic Sifter and Automated Image Analysis for CTC Enrichment
- Measurement of Gene Expression from FFPE: qNPA Versus qPCR
- Meta-Analysis of 24 Clinical Trials Where an NCI60-Gene Expression Based Cancer Drug Response Predictor Has Been Tested
- Microfabricated Magnetic Sifter for Cell Isolation and Capture
- MicroRNA 181a Level in Monocyte-Derived Microparticles Mirrors That in Monocytes During Obesity
- Multiplex Capability of a Fully-Integrated, Low-Cost, Ultra-Rapid PCR Device with Point-of-Care Applications
- Multiplex Genotyping of KRAS and BARF Mutations in a Single Reaction of Pyrosequencing: GTPlex-PyroSeq KRAS/BRAF
- Multiplexed Nanoparticle Induced Magneto-Rotation: Monitoring Morphology, Growth, Stress and Drug Sensitivity of Suspended Single Cancer Cells
- New Cellular Reporter Technologies Using X-MAN™ Cell Models
- Non-Invasive Liquid Biopsy
- Novel Bio-Informatic Strategy to Develop Highly Predictive Gene Signatures
- Nucleic Acid Purification from FFPE on the Maxwell® 16 Instrument
- Organic Nanoparticles with Anticancer Properties
- Predicting RNA-Protein Interactions Using Only Sequence Information
- Proteomics: How One Thousand Proteins in Almost One Thousand Subjects Help Us Stratify Cardiovascular Risk
- Quantitative Quality Metrics for NGS Libraries from Clinical Samples
- Rapid and Simple Method for Custom Targeted Resequencing
- Rationalization and Visualization of Non-Bonded Interactions Using Extended Hückel Theory
- Read-Through Compound 13 Restores Dystrophin Expression and Improves Muscle Function in the mdx Mouse Model for Duchenne Muscular Dystrophy
- Results from Serum-Tumorautoantibody Profiling of Breast, Colon, Lung and Prostate Cancers Using a 16k Protein Array for Improving Minimal Invasive Diagnostics
- RNA Aptamer Specific to the Metastasis-Inducing Domain of Carcinoembryonic Antigen
- RNA Assist: A Novel RNA Stabilization Reagent
- RNA Stabilization in Whole Blood: High Quality RNA with Room Temperature Handling of Human Blood Samples
- Scaffold Replacement and 3D Ligand Optimization Applied to the Discovery of Tyrosine Kinase Inhibitors
- Screening Compound Libraries for HTS and Lead Discovery Projects
- Semi-Automated Tumor Dissociation and Magnetic Isolation of Viable Cancer Stem Cells for Biomarker Identification by Gene Expression Analysis
- Sensitive and Specific PIK3CA Mutations Detection with PNA Clamping Assays
- Single Cell Digital Gene Expression of 800 mRNA Targets: Applications for Circulating Tumor Cells
- Single Cell mRNA-Seq Facilitated by Fluidigm C 1TM Single Cell AutoPrep System
- Single Chip Microfluidically Partitioned Giant Magnetoresistive Sensor Arrays Enable Sample Multiplexing in Biosensing
- Spectroscopic Detection of Circulating Tumor Cells in Head and Neck Cancer Patient Peripheral Blood Using Surface-Enhanced Raman Scattering Nanoparticles
- Strategic Applications of Flow Chemistry Within Drug Discovery
- Surfing into NGS Ocean: Guidelines for Whole-Exome Sequencing Variation Analysis and Data Visualization
- SV40 T/t-Common Polypeptide Sensitizes HER2-Overexpressing Human Cancer Cells to Anticancer Drugs Cisplatin and Doxorubicin
- Synthesis and Biological Evaluation of Urea Pyridine Derivatives as Novel Mineralocorticoid Receptor Antagonists
- The Efficient Elimination of HAMA and RF Interference Using Novel Optimization Method and Reagents
- The Gene Transfer Efficiency of Polysorbitol-Based Transporter in Salivary Glands
- Tumor Cellularity Conscious Tumor Genotyper and Analysis Pipeline for Cancer Exome Sequencing
- Understanding Myocardial Infarction Using Exploratory Pathway Analysis
- Understanding Target Engagement and Pathway Inhibition in Preclinical and Clinical Models Using Automated Image Analysis of IHC-Based Biomarkers
- Unlocking Protein Biomarkers for Translational Oncology Research
- Urinary MicroRNAs for the Detection and/or Differentiation of Prostate Cancer from Benign Prostatic Hyperplasia
- Urinary Proteomic and Transcriptomic Signatures for the Detection of Prostate Cancer in BPH Patients
- Validation of a Multiplex ADME SNP Assay for Clinical Trial Studies: The Illumina® VeraCode® ADME Core Panel – an Alternative to DMET
- Web Interface Protein Atlas (WIPA): A Data Mining Tool in Systems Pathology
- What is Needed to Establish Measurement Confidence in CTC Capture Systems
Poster abstracts are no longer being accepted on this site. If you wish to present a poster, please email Jamie Ring.
Present a Poster and Save $50!
Dedicated poster sessions for Symposia and Conference Programs.
Present your poster at both!**
Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the Program Addendum, your abstract(s) must be submitted, approved and your registration paid in full by noon on January 28, 2013.
Register online for Regular or All Access, or by phone, fax or mail. Please indicate that you would like to present a poster. Once your registration has been fully processed, we will send an email containing a unique link and instructions for submitting your abstract using our online abstract submission tool. Please see below for more information.
Reasons you should present your research poster at this conference:
- Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutes
- Your poster abstract will be published in the conference materials
- $50 off your registration fee**
Symposia Posters
At the Moscone North Convention Center - February 11-12, 2013
- Topic-specific poster sessions
- Targeted audience
Conference Program Posters
At the Moscone North Convention Center - February 13-14, 2013
- Your Poster will be available to over 3,000 delegates
- Posters will be on display for two full days in the exhibit hall
- Core Program poster competition with two $500 prizes
* CHI reserves the right to publish your poster title and abstract in various marketing materials and products.
** One poster discount per registration.
(You must be registered for a Symposium to present at the Symposia Poster Session; You must be registered for a Conference Program to present at the Conference Program Poster Session)
Note: Posters should be portrait orientation, with maximum dimensions of
36 inches wide (3 feet) x 48 inches high (4 feet).
> Click here for poster instructions